Fluid restriction versus volume expansion in children with diarrhea-associated HUS: a retrospective observational study
- 17 July 2020
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (1) , 103-109
Abstract
Background Fifty percent of patients with typical diarrhea-associated hemolytic uremic syndrome (D+HUS) require kidney replacement therapy (KRT). In these patients, dehydration worsens disease prognosis. We evaluated dialysis requirement, presence of seizures, and mortality rate among patients diagnosed with D+HUS treated with volume expansion (VE) versus fluid restriction (FR). Methods Thirty-five patients with D+HUS were enrolled; 16 received VE and 19 were historical patients who received conventional FR. Results Upon admission or during treatment, neither group presented evidence of fluid overload. The VE group received higher volumes of saline (VE 27 ml/kg [10–30] over a 3-h period vs. FR 0 ml), had higher urine output after 12 h (VE vs. FR: OR 6.2 [1.2–41.6], P = 0.03), and required less dialysis (VE 2 [12.5%, CI 95% 0–29] vs. FR 9 [47.4%, CI 95% 24–70], P = 0.035). The VE group had an absolute risk reduction of 0.34 (CI 95% 0.07–0.63); hence, three patients treated with VE were required to avoid one KRT. VE also corrected initial hyponatremia and maintained serum sodium within normal ranges. No statistical differences were observed regarding number of patients with seizures (P = 0.08) or mortality (P = 1.0). Conclusions VE markedly reduces the number of patients requiring KRT and keeps serum sodium within a normal range. We propose to initially hydrate every patient with D+HUS and without signs of fluid overload, with 10 ml/kg/h 0.9% saline solution IV, over a 3-h period. Afterwards, if urine output is ≥ 0.5 ml/kg/h, it is recommended to not dialyze and continue IV hydration schedule with isotonic (D5) saline solution, according to their needs.Keywords
This publication has 19 references indexed in Scilit:
- Serogroup-Specific Bacterial Engineered Glycoproteins as Novel Antigenic Targets for Diagnosis of Shiga Toxin-Producing-Escherichia coli-Associated Hemolytic-Uremic SyndromeJournal of Clinical Microbiology, 2015
- Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndromePediatric Nephrology, 2014
- Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome childrenPediatric Nephrology, 2012
- Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic SyndromeArchives of Pediatrics & Adolescent Medicine, 2011
- Syndrome hémolytique et urémique post-diarrhéique : Quand y penser ? Quel suivi ?Archives de Pédiatrie, 2011
- Escherichia coli O‐157‐induced hemolytic uremic syndrome: Usefulness of SCWP score for the prediction of neurological complicationPediatrics International, 2009
- Risk factors for developing severe clinical course in HUS patients: a national survey in JapanPediatrics International, 2008
- Relative Nephroprotection DuringEscherichia coliO157:H7 Infections: Association With Intravenous Volume ExpansionPediatrics, 2005
- The hemolytic-uremic syndromeThe Journal of Pediatrics, 1968
- The hemolytic-uremic syndromeThe Journal of Pediatrics, 1964